Key result
PAF-AH RH+HH genotype linked to ~44% higher ischemic stroke risk versus wild-type.
Why the study?
Are PAF-AH gene polymorphisms (R92H and V279F) associated with an increased risk of ischemic stroke?
Case-Control (n=745)
No
Are PAF-AH gene polymorphisms (R92H and V279F) associated with an increased risk of ischemic stroke?
Odds Ratio: 1.44 (95% CI 1.06–2.01)
p-value: p=0.02
The R92H polymorphism in the PAF-AH gene is associated with an increased susceptibility to ischemic stroke, particularly large-artery atherosclerotic stroke.
May support PAF-AH R92H as stroke risk marker; hypothesis-generating and should not yet change practice.
Platelet-activating factor acetylhydrolase (PAF-AH) has an important function in the pathogenesis of ischemic stroke. The aim of the present study was to investigate the correlation between the variation of polymorphisms (R92H and V279F) in PAF-AH and ischemic stroke. A total of 375 patients with ischemic stroke and 370 healthy controls were recruited into the study. Polymorphisms of V279F and R92H in PAF-AH were detected by polymerase chain reaction and DNA direct sequencing method. No significant association was observed between V279F and ischemic stroke. However, the RH+HH genotype, RH genotype and H allele of R92H were significantly associated with an increased risk of ischemic stroke (P=0.02, P=0.03 and P=0.02, respectively), In addition, these correlations remained following adjustment for confounding risk factors of stroke. Furthermore, subgroup analysis showed that a significant association with R92H was identified in the large-artery atherosclerotic stroke subgroup. These findings indicated that variation of R92H in the PAF-AH gene may contribute to ischemic stroke susceptibility in the population studied.
No takes yet. Share an insight, caveat, or question.
Yongsheng Ma (2015) conducted a case-control in Ischemic stroke (n=745). PAF-AH R92H polymorphism (HH+RH genotype) vs. RR genotype was evaluated on Risk of ischemic stroke (OR 1.44, 95% CI 1.06-2.01, p=0.02). The RH+HH genotype of the PAF-AH R92H polymorphism was significantly associated with an increased risk of ischemic stroke compared to the RR genotype (OR 1.44).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: